Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0XL1M
|
|||
| Drug Name |
6,6-fused nitrogenous heterocyclic compound 3
|
|||
| Synonyms |
PMID25656651-Compound-32c
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
F. HOFFMANN-LA ROCHE AG GAZZARD, Lewis J. HANAN, Emily KINTZ, Samuel LYSSIKATOS, Joseph P. PURKEY, Hans Edward
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H17F4N3O2
|
|||
| Canonical SMILES |
CC1=CC(=NC=C1C2=CC3=CN=C(C=C3C=C2)NC(=O)C4CC4F)C(C(F)(F)F)O
|
|||
| InChI |
1S/C21H17F4N3O2/c1-10-4-17(19(29)21(23,24)25)26-9-15(10)12-3-2-11-6-18(27-8-13(11)5-12)28-20(30)14-7-16(14)22/h2-6,8-9,14,16,19,29H,7H2,1H3,(H,27,28,30)/t14-,16+,19+/m1/s1
|
|||
| InChIKey |
LTXJULOSIPKSDB-ALKREAHSSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.